Novartis Looks to Buy French Firm to Bolster Cancer Portfolio

Photo of Novartis Looks to Buy French Firm to Bolster Cancer Portfolio
Facebook
VKontakte
share_fav

The $3.9 billion acquisition of Advanced Accelerator Applications would mark a rare deal in the pharmaceutical sector this year.

view The New York Times: Health
#novartis ag
#mergers acquisitions and divestitures
#drugs pharmaceuticals
#cancer